author-photo

Peter P. Ruvolo

University of Texas MD Anderson Cancer Center
University of Texas Health Science Center at Houston

161

Papers

5566

Citations

Citation Trend

Filter By

Papers (111) Sort By

Journal Conference Others

Combination Therapy of FLT3 Tyrosine Kinase Inhibitors and BH3 Mimetics Targeting Antiapoptotic MCL-1 Synergistically Eliminates FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and In Vivo

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
TAM kinases as regulators of cell death.

2021 Biochimica et Biophysica Acta
Show All
- Source
- Cite
- Save
Citations (1)
High Dimensional Interrogation of Stress Response Patterns and Cell Death Modes in AML

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer

2020
Show All
- Source
- Cite
- Save
Citations (7)
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization.

2020 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (25)
AML-044: LGALS1 Acts as a Pro-Survival Molecule in AML

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
AML-356: High Dimensional Analytic Approaches Identify Stressor Specific Response Patterns in AML

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
AML-211: Active Galectin 3/CD74 Axis is Associated with Poor Survival Outcome in AML

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)